Benefits of initial CT staging before sentinel lymph node biopsy in patients with head and neck cutaneous melanoma

Head & Neck ◽  
2017 ◽  
Vol 39 (11) ◽  
pp. 2301-2310 ◽  
Author(s):  
Anna Hafström ◽  
Maria Silfverschiöld ◽  
Simon S. Persson ◽  
Michelle Kanne ◽  
Christian Ingvar ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Node Biopsy

scholarly journals Sentinel Lymph Node Biopsy in Head and Neck Cutaneous Malignant Melanoma

2019 ◽  
Vol 77 (2) ◽  
pp. 129-133
Author(s):  
Ana Marta António ◽  
Cecília Moura ◽  
Carina Semedo ◽  
Sandra Bitoque ◽  
Mariluz Martins ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Primary Melanoma ◽  
Lymph Node Biopsy ◽  
Superficial Spreading ◽  
Node Biopsy ◽  
Head And Neck Melanoma

Introduction: Sentinel lymph node biopsy (SLNB) is the standard of care for cutaneous melanoma, including head and neck melanoma. The aim of this study was to analyze and characterize SLNB in a population of head and neck melanoma patients. Methods: A unicentric, retrospective study on patients with cutaneous head and neck melanoma who underwent SLNB in the Department of Head and Neck Surgery at the Portuguese Institute of Oncology (IPO) Lisbon between January 2010 and December 2017 was performed. The location of primary melanoma, the identification of SLN, the number of the excised SLN, its lymphatic basin origin and the presence of infraclinic metastasis were analysed. Results:  Ninety-eight patients were eligible to undergo SLNB during the observation period. The most frequent locations of primary melanoma were the scalp (24.5%) and the auricular and periauricular region (23.5%) and the most frequent variants were the superficial spreading melanoma (40.8%) and nodular melanoma (30.6%). SLNB was successfully executed in 78 patients (79.6%). A mean of 3.8 lymph-nodes per patient were excised and in 16.7% SLN were excised in more than one lymphatic basin. The SLN were identified in parotid region (39.8%), level II (29.5%) and level V (18.2%). SLN metastases were detected in 13 patients (16.7%). Conclusion: Surgical approach of head and neck cutaneous melanoma is particularly complex. The redundancy of lymphatic system, the multiple SLN and SLN basins influence the SLNB success and may contribute to high rates of false-negatives with its prognostic implications. All patients should be carefully monitored.  

scholarly journals Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline

2019 ◽  
Vol 26 (4) ◽  
Author(s):  
F. C. Wright ◽  
L. H. Souter ◽  
S. Kellett ◽  
A. Easson ◽  
C. Murray ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Systematic Reviews ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Node Biopsy ◽  
Primary Literature ◽  
Excision Margins

Background  For patients who are diagnosed with early-stage cutaneous melanoma, the principal therapy is wide surgical excision of the primary tumour and assessment of lymph nodes. The purpose of the present guideline was to update the 2010 Cancer Care Ontario guideline on wide local excision margins and sentinel lymph node biopsy (SLNB), including treatment of the positive sentinel node, for melanomas of the trunk, extremities, and head and neck.Methods  Using Ovid, the MEDLINE and EMBASE electronic databases were systematically searched for systematic reviews and primary literature evaluating narrow compared with wide excision margins and the use of SLNB for melanoma of the truck and extremities and of the head and neck. Search timelines ran from 2010 through week 25 of 2017.Results  Four systematic reviews were chosen for inclusion in the evidence base. Where systematic reviews were available, the search of the primary literature was conducted starting from the end date of the search in the reviews. Where systematic reviews were absent, the search for primary literature ran from 2010 forward. Of 1213 primary studies identified, 8 met the inclusion criteria. Two randomized controlled trials were used to inform the recommendation on completion lymph node dissection.Key updated recommendations include:■ Wide local excision margins should be 2 cm for melanomas of the trunk, extremities, and head and neck that exceed 2 mm in depth.■ SLNB should be offered to patients with melanomas of the trunk, extremities, and head and neck that exceed 0.8 mm in depth.■ Patients with sentinel node metastasis should be considered for nodal observation with ultrasonography rather than for completion lymph node dissection.Conclusions  Recommendations for primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in patients with cutaneous melanoma have been updated based on the current literature.

Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system

2018 ◽  
Vol 39 (5) ◽  
pp. 485-488 ◽  
Author(s):  
Andrew M. Vahabzadeh-Hagh ◽  
Keith E. Blackwell ◽  
Elliot Abemayor ◽  
Maie A. St. John
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Indocyanine Green ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Node Biopsy

Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy

Head & Neck ◽  
2006 ◽  
Vol 28 (3) ◽  
pp. 249-255 ◽  
Author(s):  
Doris Lin ◽  
Benjamin L. Franc ◽  
Mohammed Kashani-Sabet ◽  
Mark I. Singer
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Lymphatic Drainage ◽  
Lymph Node Biopsy ◽  
Drainage Patterns ◽  
Node Biopsy

Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy

Head & Neck ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 1116-1121 ◽  
Author(s):  
Melinda V. Davis-Malesevich ◽  
Ryan Goepfert ◽  
Mark Kubik ◽  
Dianna B. Roberts ◽  
Jeffrey N. Myers ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Node Biopsy

scholarly journals Patterns of Drainage and Recurrence Following Sentinel Lymph Node Biopsy for Cutaneous Melanoma of the Head and Neck

2004 ◽  
Vol 130 (7) ◽  
pp. 844 ◽  
Author(s):  
Timothy R. Fincher ◽  
John C. O'Brien ◽  
Todd M. McCarty ◽  
Tammy L. Fisher ◽  
John T. Preskitt ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Node Biopsy

scholarly journals 489 The Role of Sentinel Lymph Node Biopsy in Cutaneous Head and Neck Melanoma: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
E Johnston ◽  
S Taylor ◽  
F Bannon ◽  
S McAllister
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Head And Neck ◽  
False Negative ◽  
False Negative Rate ◽  
Lymph Node Biopsy ◽  
Node Biopsy ◽  
Negative Rate ◽  
Sentinel Node Identification

Abstract Introduction and Aims The aim of this systematic review is to provide an up-to-date evaluation of the role and test performance of sentinel lymph node biopsy (SLNB) in the head and neck. Method This review follows the PRISMA guidelines. Database searches for MEDLINE and EMBASE were constructed to retrieve human studies published between 1st January 2010 and 1st July 2020 assessing the role and accuracy of sentinel lymph node biopsy in cutaneous malignant melanoma of the head and neck. Articles were independently screened by two reviewers and critically appraised using the MINORS criteria. The primary outcomes consisted of the sentinel node identification rate and test-performance measures, including the false-negative rate and the posttest probability negative. Results A total of 27 studies, including 4688 patients, met the eligibility criteria. Statistical analysis produced weighted summary estimates for the sentinel node identification rate of 97.3% (95% CI, 95.9% to 98.6%), the false-negative rate of 21.3% (95% CI, 17.0% to 25.4%) and the posttest probability negative of 4.8% (95% CI, 3.9% to 5.8%). Discussion Sentinel lymph node biopsy is accurate and feasible in the head and neck. Despite technical improvements in localisation techniques, the false negative rate remains disproportionately higher than for melanoma in other anatomical sites.

Surgical Management of Sentinel Lymph Node Biopsy Outside Major Nodal Basin in Patients with Cutaneous Melanoma

2013 ◽  
Vol 21 (1) ◽  
pp. 300-305 ◽  
Author(s):  
Corrado Caracò ◽  
Ugo Marone ◽  
Gianluca Di Monta ◽  
Luigi Aloj ◽  
Corradina Caracò ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Surgical Management ◽  
Cutaneous Melanoma ◽  
Lymph Node Biopsy ◽  
Nodal Basin ◽  
Node Biopsy
Sign in / Sign up

Export Citation Format

Share Document